Head-to-head · Cost-Efficiency Index
Navio MD vs Ozari Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Navio MD
Shoppers who want compounded tirzepatide with a brand-name fallback path on the same platform, 48 states.
Visit Navio MDOzari Health
Cost-first shoppers who want legitScript-certified compounded GLP-1 from as low as $86/month.
Visit Ozari HealthThe verdict
Navio MD and Ozari Health tie on the Cost-Efficiency Index at 73/100, so neither wins outright on the numbers. For most shoppers we'd start with Navio MD (ranked #69, a hair above #70) — Shoppers who want compounded tirzepatide with a brand-name fallback path on the same platform, 48 states. But Ozari Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Navio MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Navio MD | Ozari Health |
|---|---|---|
| Cost-Efficiency Index | 73/100 | 73/100 |
| Semaglutide / mo | $345/mo (brand Ozempic) | $86/mo (3-mo starter plan, new patients only, compounded) |
| Tirzepatide / mo | $189/mo (starting dose, compounded) | $125/mo (3-mo starter plan, new patients only, compounded) |
| Semaglutide / yr (modeled) | $4,140 | $1,032 |
| Tirzepatide / yr (modeled) | $2,268 | $1,500 |
| Coverage | 48 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #69 | #70 |
Navio MD
73/100Where the value is
- LegitScript certified with board-certified providers claimed
- Both compounded and brand-name options on one platform
- 48-state coverage with the two exclusions (AL, MS) explicitly disclosed rather than hidden
The tradeoffs
- No compounded semaglutide offered — only brand-name Ozempic for that molecule, at a much higher price than compounded competitors
- All prices are 'as low as' floors; the exact dose tied to each starting price is not published
Ozari Health
73/100Where the value is
- Very low entry pricing — compounded semaglutide from $86/month
- LegitScript certified and operated by a named entity (Ozari LLC)
- Board-certified physicians; meds compounded in 503A and 503B facilities
The tradeoffs
- The advertised rates are three-month starter plans for first-time GLP-1 users, billed $257 and $375 up front; month-to-month is $175 and $235
- Canceling an annual or semi-annual plan early re-prices the installments already shipped at the standard monthly rate and charges the difference
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.